ID   PLXB3_HUMAN             Reviewed;        1909 AA.
AC   Q9ULL4; B7Z3E6; F5H773; Q9HDA4;
DT   31-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   31-AUG-2004, sequence version 2.
DT   10-MAY-2017, entry version 138.
DE   RecName: Full=Plexin-B3;
DE   Flags: Precursor;
GN   Name=PLXNB3; Synonyms=KIAA1206, PLXN6;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RA   Veske A., Michelson P., Finckh U., Gal A.;
RT   "Cloning and characterization of the new human plexin family member,
RT   plexin related protein.";
RL   Submitted (MAY-1999) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=10574462; DOI=10.1093/dnares/6.5.337;
RA   Nagase T., Ishikawa K., Kikuno R., Hirosawa M., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XV.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 6:337-345(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANTS
RP   ILE-598; ASP-1156 AND THR-1535.
RC   TISSUE=Hippocampus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [5]
RP   INTERACTION WITH MET AND MST1R.
RX   PubMed=15184888; DOI=10.1038/sj.onc.1207650;
RA   Conrotto P., Corso S., Gamberini S., Comoglio P.M., Giordano S.;
RT   "Interplay between scatter factor receptors and B plexins controls
RT   invasive growth.";
RL   Oncogene 23:5131-5137(2004).
RN   [6]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=15218527; DOI=10.1038/sj.embor.7400189;
RA   Artigiani S., Conrotto P., Fazzari P., Gilestro G.F., Barberis D.,
RA   Giordano S., Comoglio P.M., Tamagnone L.;
RT   "Plexin-B3 is a functional receptor for semaphorin 5A.";
RL   EMBO Rep. 5:710-714(2004).
RN   [7]
RP   SUBUNIT, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=16122393; DOI=10.1186/1471-2202-6-53;
RA   Hartwig C., Veske A., Krejcova S., Rosenberger G., Finckh U.;
RT   "Plexin B3 promotes neurite outgrowth, interacts homophilically, and
RT   interacts with Rin.";
RL   BMC Neurosci. 6:53-53(2005).
RN   [8]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=20696765; DOI=10.1074/jbc.M110.120451;
RA   Li X., Lee A.Y.;
RT   "Semaphorin 5A and plexin-B3 inhibit human glioma cell motility
RT   through RhoGDIalpha-mediated inactivation of Rac1 GTPase.";
RL   J. Biol. Chem. 285:32436-32445(2010).
RN   [9]
RP   FUNCTION, INTERACTION WITH FSCN1, AND TISSUE SPECIFICITY.
RX   PubMed=21706053; DOI=10.1038/onc.2011.256;
RA   Li X., Law J.W., Lee A.Y.;
RT   "Semaphorin 5A and plexin-B3 regulate human glioma cell motility and
RT   morphology through Rac1 and the actin cytoskeleton.";
RL   Oncogene 31:595-610(2012).
CC   -!- FUNCTION: Receptor for SEMA5A that plays a role in axon guidance,
CC       invasive growth and cell migration. Stimulates neurite outgrowth
CC       and mediates Ca(2+)/Mg(2+)-dependent cell aggregation. In glioma
CC       cells, SEMA5A stimulation of PLXNB3 results in the disassembly of
CC       F-actin stress fibers, disruption of focal adhesions and cellular
CC       collapse as well as inhibition of cell migration and invasion
CC       through ARHGDIA-mediated inactivation of RAC1.
CC       {ECO:0000269|PubMed:15218527, ECO:0000269|PubMed:20696765,
CC       ECO:0000269|PubMed:21706053}.
CC   -!- SUBUNIT: Interacts (via cytoplasmic domain) with RAC1 and ARHGDIA
CC       (By similarity). Binds MET and MST1R. Interacts (via cytoplasmic
CC       domain) with FSCN1. Interacts with RIT2/RIN. May form homodimers
CC       (via Sema domain). {ECO:0000250, ECO:0000269|PubMed:15184888,
CC       ECO:0000269|PubMed:16122393, ECO:0000269|PubMed:21706053}.
CC   -!- INTERACTION:
CC       Q16658:FSCN1; NbExp=2; IntAct=EBI-311073, EBI-351076;
CC       P08581:MET; NbExp=2; IntAct=EBI-311073, EBI-1039152;
CC       Q04912:MST1R; NbExp=2; IntAct=EBI-311073, EBI-2637518;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15218527,
CC       ECO:0000269|PubMed:16122393}; Single-pass type I membrane protein
CC       {ECO:0000269|PubMed:15218527, ECO:0000269|PubMed:16122393}.
CC       Note=Colocalizes with RIT2/RIN at the plasma membrane.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9ULL4-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9ULL4-2; Sequence=VSP_044467;
CC   -!- TISSUE SPECIFICITY: Expression detected in Purkinje and granular
CC       cells in cerebellum, and in brain neocortex but not in corpus
CC       callosum. Expressed in glioma cells and embryonic kidney cells (at
CC       protein level). Expressed in brain, liver, pancreas and placenta,
CC       with weak expression detected also in lung and kidney. Expressed
CC       in several glioma cell lines. {ECO:0000269|PubMed:16122393,
CC       ECO:0000269|PubMed:20696765, ECO:0000269|PubMed:21706053}.
CC   -!- SIMILARITY: Belongs to the plexin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA86520.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF149019; AAG01376.1; -; mRNA.
DR   EMBL; AB033032; BAA86520.1; ALT_INIT; mRNA.
DR   EMBL; AK295762; BAH12182.1; -; mRNA.
DR   EMBL; U52111; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS14729.1; -. [Q9ULL4-1]
DR   CCDS; CCDS55536.1; -. [Q9ULL4-2]
DR   RefSeq; NP_001156729.1; NM_001163257.1. [Q9ULL4-2]
DR   RefSeq; NP_005384.2; NM_005393.2. [Q9ULL4-1]
DR   UniGene; Hs.632833; -.
DR   ProteinModelPortal; Q9ULL4; -.
DR   SMR; Q9ULL4; -.
DR   BioGrid; 111378; 6.
DR   IntAct; Q9ULL4; 11.
DR   MINT; MINT-2822157; -.
DR   STRING; 9606.ENSP00000442736; -.
DR   iPTMnet; Q9ULL4; -.
DR   PhosphoSitePlus; Q9ULL4; -.
DR   BioMuta; PLXNB3; -.
DR   DMDM; 51701857; -.
DR   PaxDb; Q9ULL4; -.
DR   PeptideAtlas; Q9ULL4; -.
DR   PRIDE; Q9ULL4; -.
DR   DNASU; 5365; -.
DR   Ensembl; ENST00000361971; ENSP00000355378; ENSG00000198753. [Q9ULL4-1]
DR   Ensembl; ENST00000538966; ENSP00000442736; ENSG00000198753. [Q9ULL4-2]
DR   GeneID; 5365; -.
DR   KEGG; hsa:5365; -.
DR   UCSC; uc004fii.3; human. [Q9ULL4-1]
DR   CTD; 5365; -.
DR   DisGeNET; 5365; -.
DR   GeneCards; PLXNB3; -.
DR   H-InvDB; HIX0093726; -.
DR   HGNC; HGNC:9105; PLXNB3.
DR   HPA; HPA048046; -.
DR   MIM; 300214; gene.
DR   neXtProt; NX_Q9ULL4; -.
DR   OpenTargets; ENSG00000198753; -.
DR   PharmGKB; PA33431; -.
DR   eggNOG; KOG3610; Eukaryota.
DR   eggNOG; ENOG410XR88; LUCA.
DR   GeneTree; ENSGT00760000119048; -.
DR   HOGENOM; HOG000231376; -.
DR   HOVERGEN; HBG053404; -.
DR   InParanoid; Q9ULL4; -.
DR   KO; K06821; -.
DR   OMA; WRCHWCP; -.
DR   OrthoDB; EOG091G00EK; -.
DR   PhylomeDB; Q9ULL4; -.
DR   TreeFam; TF312962; -.
DR   Reactome; R-HSA-416700; Other semaphorin interactions.
DR   SignaLink; Q9ULL4; -.
DR   ChiTaRS; PLXNB3; human.
DR   GeneWiki; PLXNB3; -.
DR   GenomeRNAi; 5365; -.
DR   PRO; PR:Q9ULL4; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000198753; -.
DR   CleanEx; HS_PLXNB3; -.
DR   ExpressionAtlas; Q9ULL4; baseline and differential.
DR   Genevisible; Q9ULL4; HS.
DR   GO; GO:0009986; C:cell surface; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0098632; F:protein binding involved in cell-cell adhesion; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:UniProtKB.
DR   GO; GO:0051022; F:Rho GDP-dissociation inhibitor binding; IEA:Ensembl.
DR   GO; GO:0017154; F:semaphorin receptor activity; IDA:UniProtKB.
DR   GO; GO:0048675; P:axon extension; IBA:GO_Central.
DR   GO; GO:0060326; P:cell chemotaxis; IDA:UniProtKB.
DR   GO; GO:0007156; P:homophilic cell adhesion via plasma membrane adhesion molecules; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0007162; P:negative regulation of cell adhesion; IDA:UniProtKB.
DR   GO; GO:0030336; P:negative regulation of cell migration; IMP:UniProtKB.
DR   GO; GO:0034260; P:negative regulation of GTPase activity; IMP:UniProtKB.
DR   GO; GO:0010593; P:negative regulation of lamellipodium assembly; ISS:UniProtKB.
DR   GO; GO:0050918; P:positive chemotaxis; IDA:UniProtKB.
DR   GO; GO:0050772; P:positive regulation of axonogenesis; IBA:GO_Central.
DR   GO; GO:0001938; P:positive regulation of endothelial cell proliferation; IMP:UniProtKB.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0008360; P:regulation of cell shape; IBA:GO_Central.
DR   GO; GO:0071526; P:semaphorin-plexin signaling pathway; IDA:UniProtKB.
DR   Gene3D; 2.130.10.10; -; 1.
DR   Gene3D; 2.60.40.10; -; 5.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR014756; Ig_E-set.
DR   InterPro; IPR002909; IPT.
DR   InterPro; IPR031148; Plexin.
DR   InterPro; IPR013548; Plexin_cytoplasmic_RasGAP_dom.
DR   InterPro; IPR002165; Plexin_repeat.
DR   InterPro; IPR016201; PSI.
DR   InterPro; IPR008936; Rho_GTPase_activation_prot.
DR   InterPro; IPR001627; Semap_dom.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom.
DR   PANTHER; PTHR22625; PTHR22625; 1.
DR   Pfam; PF08337; Plexin_cytopl; 1.
DR   Pfam; PF01437; PSI; 1.
DR   Pfam; PF01403; Sema; 1.
DR   Pfam; PF01833; TIG; 3.
DR   SMART; SM00429; IPT; 3.
DR   SMART; SM00423; PSI; 3.
DR   SMART; SM00630; Sema; 1.
DR   SUPFAM; SSF101912; SSF101912; 1.
DR   SUPFAM; SSF48350; SSF48350; 2.
DR   SUPFAM; SSF81296; SSF81296; 5.
DR   PROSITE; PS51004; SEMA; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Complete proteome;
KW   Disulfide bond; Glycoprotein; Membrane; Neurogenesis; Polymorphism;
KW   Receptor; Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     44       {ECO:0000255}.
FT   CHAIN        45   1909       Plexin-B3.
FT                                /FTId=PRO_0000024674.
FT   TOPO_DOM     45   1255       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1256   1276       Helical. {ECO:0000255}.
FT   TOPO_DOM   1277   1909       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       45    471       Sema. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00352}.
FT   DOMAIN      473    526       PSI 1.
FT   DOMAIN      620    682       PSI 2.
FT   DOMAIN      787    833       PSI 3.
FT   DOMAIN      835    925       IPT/TIG 1.
FT   DOMAIN      927   1012       IPT/TIG 2.
FT   DOMAIN     1015   1145       IPT/TIG 3.
FT   DOMAIN     1159   1244       IPT/TIG 4.
FT   CARBOHYD     51     51       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    231    231       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    615    615       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    802    802       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    900    900       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    957    957       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1101   1101       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1218   1218       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     98    107       {ECO:0000255|PROSITE-ProRule:PRU00352}.
FT   DISULFID    132    140       {ECO:0000255|PROSITE-ProRule:PRU00352}.
FT   DISULFID    267    370       {ECO:0000255|PROSITE-ProRule:PRU00352}.
FT   DISULFID    283    315       {ECO:0000255|PROSITE-ProRule:PRU00352}.
FT   DISULFID    333    357       {ECO:0000255|PROSITE-ProRule:PRU00352}.
FT   DISULFID    474    491       {ECO:0000255|PROSITE-ProRule:PRU00352}.
FT   DISULFID    480    525       {ECO:0000255|PROSITE-ProRule:PRU00352}.
FT   DISULFID    483    500       {ECO:0000255|PROSITE-ProRule:PRU00352}.
FT   DISULFID    494    506       {ECO:0000255|PROSITE-ProRule:PRU00352}.
FT   DISULFID    562    580       {ECO:0000255|PROSITE-ProRule:PRU00352}.
FT   VAR_SEQ       1     15       MCHAAQETPLLHHFM -> MELTPASSLTCSLLSPRLPGSF
FT                                PQLRRVPPCSRPWLPK (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_044467.
FT   VARIANT     126    126       A -> T (in dbSNP:rs34360382).
FT                                /FTId=VAR_050601.
FT   VARIANT     598    598       V -> I (in dbSNP:rs2266879).
FT                                {ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_019681.
FT   VARIANT    1156   1156       E -> D (in dbSNP:rs6643791).
FT                                {ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_061538.
FT   VARIANT    1535   1535       M -> T (in dbSNP:rs5987155).
FT                                {ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_019682.
FT   VARIANT    1651   1651       E -> A (in dbSNP:rs34762690).
FT                                /FTId=VAR_068807.
FT   CONFLICT    149    149       A -> V (in Ref. 3; BAH12182).
FT                                {ECO:0000305}.
FT   CONFLICT    300    300       L -> P (in Ref. 3; BAH12182).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1909 AA;  206847 MW;  11753CD58C7AC226 CRC64;
     MCHAAQETPL LHHFMAPVMA RWPPFGLCLL LLLLSPPPLP LTGAHRFSAP NTTLNHLALA
     PGRGTLYVGA VNRLFQLSPE LQLEAVAVTG PVIDSPDCVP FRDPAECPQA QLTDNANQLL
     LVSSRAQELV ACGQVRQGVC ETRRLGDVAE VLYQAEDPGD GQFVAANTPG VATVGLVVPL
     PGRDLLLVAR GLAGKLSAGV PPLAIRQLAG SQPFSSEGLG RLVVGDFSDY NNSYVGAFAD
     ARSAYFVFRR RGARAQAEYR SYVARVCLGD TNLYSYVEVP LACQGQGLIQ AAFLAPGTLL
     GVFAAGPRGT QAALCAFPMV ELGASMEQAR RLCYTAGGRG PSGAEEATVE YGVTSRCVTL
     PLDSPESYPC GDEHTPSPIA GRQPLEVQPL LKLGQPVSAV AALQADGHMI AFLGDTQGQL
     YKVFLHGSQG QVYHSQQVGP PGSAISPDLL LDSSGSHLYV LTAHQVDRIP VAACPQFPDC
     ASCLQAQDPL CGWCVLQGRC TRKGQCGRAG QLNQWLWSYE EDSHCLHIQS LLPGHHPRQE
     QGQVTLSVPR LPILDADEYF HCAFGDYDSL AHVEGPHVAC VTPPQDQVPL NPPGTDHVTV
     PLALMFEDVT VAATNFSFYD CSAVQALEAA APCRACVGSI WRCHWCPQSS HCVYGEHCPE
     GERTIYSAQE VDIQVRGPGA CPQVEGLAGP HLVPVGWESH LALRVRNLQH FRGLPASFHC
     WLELPGELRG LPATLEETAG DSGLIHCQAH QFYPSMSQRE LPVPIYVTQG EAQRLDNTHA
     LYVILYDCAM GHPDCSHCQA ANRSLGCLWC ADGQPACRYG PLCPPGAVEL LCPAPSIDAV
     EPLTGPPEGG LALTILGSNL GRAFADVQYA VSVASRPCNP EPSLYRTSAR IVCVTSPAPN
     GTTGPVRVAI KSQPPGISSQ HFTYQDPVLL SLSPRWGPQA GGTQLTIRGQ HLQTGGNTSA
     FVGGQPCPIL EPVCPEAIVC RTRPQAAPGE AAVLVVFGHA QRTLLASPFR YTANPQLVAA
     EPSASFRGGG RLIRVRGTGL DVVQRPLLSV WLEADAEVQA SRAQPQDPQP RRSCGAPAAD
     PQACIQLGGG LLQCSTVCSV NSSSLLLCRS PAVPDRAHPQ RVFFTLDNVQ VDFASASGGQ
     GFLYQPNPRL APLSREGPAR PYRLKPGHVL DVEGEGLNLG ISKEEVRVHI GRGECLVKTL
     TRTHLYCEPP AHAPQPANGS GLPQFVVQMG NVQLALGPVQ YEAEPPLSAF PVEAQAGVGM
     GAAVLIAAVL LLTLMYRHKS KQALRDYQKV LVQLESLETG VGDQCRKEFT DLMTEMTDLS
     SDLEGSGIPF LDYRTYAERA FFPGHGGCPL QPKPEGPGED GHCATVRQGL TQLSNLLNSK
     LFLLTLIHTL EEQPSFSQRD RCHVASLLSL ALHGKLEYLT DIMRTLLGDL AAHYVHRNPK
     LMLRRTETMV EKLLTNWLSI CLYAFLREVA GEPLYMLFRA IQYQVDKGPV DAVTGKAKRT
     LNDSRLLRED VEFQPLTLMV LVGPGAGGAA GSSEMQRVPA RVLDTDTITQ VKEKVLDQVY
     KGTPFSQRPS VHALDLEWRS GLAGHLTLSD EDLTSVTQNH WKRLNTLQHY KVPDGATVGL
     VPQLHRGSTI SQSLAQRCPL GENIPTLEDG EEGGVCLWHL VKATEEPEGA KVRCSSLRER
     EPARAKAIPE IYLTRLLSMK GTLQKFVDDT FQAILSVNRP IPIAVKYLFD LLDELAEKHG
     IEDPGTLHIW KTNSLLLRFW VNALKNPQLI FDVRVSDNVD AILAVIAQTF IDSCTTSEHK
     VGRDSPVNKL LYAREIPRYK QMVERYYADI RQSSPASYQE MNSALAELSG NYTSAPHCLE
     ALQELYNHIH RYYDQIISAL EEDPVGQKLQ LACRLQQVAA LVENKVTDL
//
